Genetic Predisposition to Solid Pediatric Cancers

Progresses over the past years have extensively improved our capacity to use genome-scale analyses—including high-density genotyping and exome and genome sequencing—to identify the genetic basis of pediatric tumors. In particular, exome sequencing has contributed to the evidence that about 10% of ch...

Full description

Bibliographic Details
Main Authors: Mario Capasso, Annalaura Montella, Matilde Tirelli, Teresa Maiorino, Sueva Cantalupo, Achille Iolascon
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2020.590033/full
id doaj-4116e4e63c6242a0830ff6251685d6c0
record_format Article
spelling doaj-4116e4e63c6242a0830ff6251685d6c02020-11-25T03:38:35ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2020-10-011010.3389/fonc.2020.590033590033Genetic Predisposition to Solid Pediatric CancersMario Capasso0Mario Capasso1Annalaura Montella2Matilde Tirelli3Matilde Tirelli4Teresa Maiorino5Teresa Maiorino6Sueva Cantalupo7Sueva Cantalupo8Achille Iolascon9Achille Iolascon10Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Naples, ItalyCEINGE Biotecnologie Avanzate, Naples, ItalyCEINGE Biotecnologie Avanzate, Naples, ItalyCEINGE Biotecnologie Avanzate, Naples, ItalyEuropean School of Molecular Medicine, Università Degli Studi di Milano, Milan, ItalyDipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Naples, ItalyCEINGE Biotecnologie Avanzate, Naples, ItalyDipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Naples, ItalyCEINGE Biotecnologie Avanzate, Naples, ItalyDipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Naples, ItalyCEINGE Biotecnologie Avanzate, Naples, ItalyProgresses over the past years have extensively improved our capacity to use genome-scale analyses—including high-density genotyping and exome and genome sequencing—to identify the genetic basis of pediatric tumors. In particular, exome sequencing has contributed to the evidence that about 10% of children and adolescents with tumors have germline genetic variants associated with cancer predisposition. In this review, we provide an overview of genetic variations predisposing to solid pediatric tumors (medulloblastoma, ependymoma, astrocytoma, neuroblastoma, retinoblastoma, Wilms tumor, osteosarcoma, rhabdomyosarcoma, and Ewing sarcoma) and outline the biological processes affected by the involved mutated genes. A careful description of the genetic basis underlying a large number of syndromes associated with an increased risk of pediatric cancer is also reported. We place particular emphasis on the emerging view that interactions between germline and somatic alterations are a key determinant of cancer development. We propose future research directions, which focus on the biological function of pediatric risk alleles and on the potential links between the germline genome and somatic changes. Finally, the importance of developing new molecular diagnostic tests including all the identified risk germline mutations and of considering the genetic predisposition in screening tests and novel therapies is emphasized.https://www.frontiersin.org/articles/10.3389/fonc.2020.590033/fullgenetic predispositiongermline variantscancer predisposition genespediatric tumorscancer susceptibilitygermline-somatic interaction
collection DOAJ
language English
format Article
sources DOAJ
author Mario Capasso
Mario Capasso
Annalaura Montella
Matilde Tirelli
Matilde Tirelli
Teresa Maiorino
Teresa Maiorino
Sueva Cantalupo
Sueva Cantalupo
Achille Iolascon
Achille Iolascon
spellingShingle Mario Capasso
Mario Capasso
Annalaura Montella
Matilde Tirelli
Matilde Tirelli
Teresa Maiorino
Teresa Maiorino
Sueva Cantalupo
Sueva Cantalupo
Achille Iolascon
Achille Iolascon
Genetic Predisposition to Solid Pediatric Cancers
Frontiers in Oncology
genetic predisposition
germline variants
cancer predisposition genes
pediatric tumors
cancer susceptibility
germline-somatic interaction
author_facet Mario Capasso
Mario Capasso
Annalaura Montella
Matilde Tirelli
Matilde Tirelli
Teresa Maiorino
Teresa Maiorino
Sueva Cantalupo
Sueva Cantalupo
Achille Iolascon
Achille Iolascon
author_sort Mario Capasso
title Genetic Predisposition to Solid Pediatric Cancers
title_short Genetic Predisposition to Solid Pediatric Cancers
title_full Genetic Predisposition to Solid Pediatric Cancers
title_fullStr Genetic Predisposition to Solid Pediatric Cancers
title_full_unstemmed Genetic Predisposition to Solid Pediatric Cancers
title_sort genetic predisposition to solid pediatric cancers
publisher Frontiers Media S.A.
series Frontiers in Oncology
issn 2234-943X
publishDate 2020-10-01
description Progresses over the past years have extensively improved our capacity to use genome-scale analyses—including high-density genotyping and exome and genome sequencing—to identify the genetic basis of pediatric tumors. In particular, exome sequencing has contributed to the evidence that about 10% of children and adolescents with tumors have germline genetic variants associated with cancer predisposition. In this review, we provide an overview of genetic variations predisposing to solid pediatric tumors (medulloblastoma, ependymoma, astrocytoma, neuroblastoma, retinoblastoma, Wilms tumor, osteosarcoma, rhabdomyosarcoma, and Ewing sarcoma) and outline the biological processes affected by the involved mutated genes. A careful description of the genetic basis underlying a large number of syndromes associated with an increased risk of pediatric cancer is also reported. We place particular emphasis on the emerging view that interactions between germline and somatic alterations are a key determinant of cancer development. We propose future research directions, which focus on the biological function of pediatric risk alleles and on the potential links between the germline genome and somatic changes. Finally, the importance of developing new molecular diagnostic tests including all the identified risk germline mutations and of considering the genetic predisposition in screening tests and novel therapies is emphasized.
topic genetic predisposition
germline variants
cancer predisposition genes
pediatric tumors
cancer susceptibility
germline-somatic interaction
url https://www.frontiersin.org/articles/10.3389/fonc.2020.590033/full
work_keys_str_mv AT mariocapasso geneticpredispositiontosolidpediatriccancers
AT mariocapasso geneticpredispositiontosolidpediatriccancers
AT annalauramontella geneticpredispositiontosolidpediatriccancers
AT matildetirelli geneticpredispositiontosolidpediatriccancers
AT matildetirelli geneticpredispositiontosolidpediatriccancers
AT teresamaiorino geneticpredispositiontosolidpediatriccancers
AT teresamaiorino geneticpredispositiontosolidpediatriccancers
AT suevacantalupo geneticpredispositiontosolidpediatriccancers
AT suevacantalupo geneticpredispositiontosolidpediatriccancers
AT achilleiolascon geneticpredispositiontosolidpediatriccancers
AT achilleiolascon geneticpredispositiontosolidpediatriccancers
_version_ 1724541633971617792